Aaron P. Brown, MD
Everett, WA 98201
Providence Regional Cancer Partnership
1717 13th Street, Everett, WA 98201
About Aaron P. Brown
I am grateful to be able to be a part of my patients’ lives as they face such a challenging diagnosis. At the Providence Regional Cancer Partnership, I am pleased to be a part of team with the expertise, resources and mission to provide high quality cancer care tailored to the needs of each individual patient. To accomplish that, the Radiation Oncology Department uses state-of-the-art linear accelerators, brachytherapy and radioligand treatments delivered by a team of professionals singularly focused on the patient experience. I’m thankful for my colleagues in surgery and medical oncology on our multidisciplinary team at PRCP for their expertise in managing a complex disease and for all I learn from them. We listen to and learn from our patients as we go through this journey together.
University of Utah School of Medicine
2009
Intermountain Medical Center Transitional Year Program
2010
National Cancer Institute
2008
MD Anderson Cancer Center Medical Oncology
2014
Northwest Washington Radiation Oncology Associates
- American Board of Radiology, Radiation Oncology
- The Risk of Second Primary Malignancies up to Three Decades after the Treatment of Differentiated Thyroid Cancer. J Clin Endocrinol Metab. 2008 Feb 1; 93(2): 504–515.
- Performing Nondiagnostic Research Biopsies in Irradiated Tissue: A Review of Scientific, Clinical, and Ethical Considerations. J Clin Oncol. 2008 Aug 20; 26(24): 3987-3994.
- Clinical Biomarkers of Angiogenesis Inhibition. Cancer and Metastasis Rev. 2008 Sept; 27(3): 415-434.
- In Vitro and in Vivo Radiosensitization with AZD6244 (ARRY-142886), an Inhibitor of Mitogen Activated Protein Kinase/Extracellular Signal-regulated Kinase 1/2 kinase. Clin Cancer Res. 2009 May 1; 15(9): 3050-7.
- Evaluation of the Fullerene Compound DF-1 as a Radiation Protector. Radiat Oncol. 2010 May 11; 5(1):34.
- A Population-Based Study of Subsequent Primary Malignancies after Endometrial Cancer: Genetic, Environmental and Treatment-Related Associations. Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):127-35.
- A 4DRT Simulation Study Using a Synthetic 3.5 D CT Image with Motion-free Target of Lung Cancer Based on 4D CT. Int J Biomed Eng Technol. 2012; 8(2/3):167-181.
- Proton Beam Craniospinal Irradiation Reduces Acute Toxicity for Adults with Medulloblastoma. Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):277-284.
- Survival Analysis of Endometrial Cancer Patients with Positive Lymph Nodes. Int J Gynecol Cancer. 2013 Jun;23(5):861-8.
- Involved-Field Radiation Therapy for Locoregionally Recurrent Ovarian Cancer. Gynecol Oncol. 2013 Aug 1;130(2):300-305.
- Convergence of nanotechnology with radiation therapy—insights and implications for clinical translation. Transl Cancer Res. 2013 August;2(2)
- Improving Prostate Brachytherapy Quality Assurance with MRI-based Sector Analysis in a Phase II Prospective Trial. Brachytherapy 2013 Sept-Oct;12(5):401-407.
- Technique, Outcomes, and Acute Toxicities in Adults Treated with Proton Beam Craniospinal Irradiation. Neuro Oncol. 2014 Jan;16(2):303-309.
- Survival Analysis of Cancer Patients with FIGO Stage IIIA Endometrial Cancer. Am J Clin Oncol. Published online Jun 14 2013.
- Malignant phyllodes tumor of the breast: Is adjuvant radiotherapy necessary? In: Hayat MA, ed. Methods of Cancer Diagnosis, Therapy and Prognosis: Breast Carcinoma. Netherlands: Springer; 2009:625-636. Medical Editor for Gaffney DK, ed: Radiation Oncology: Imaging and Treatment. Salt Lake City: Amirsys Publishing Inc; 2013
I enjoy family time, biking, hiking, backpacking, sports and enjoying good food.